CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended		178 Months Ended
	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2013
Cash flows from operating activities:
Net loss	$ (12,886,700)	$ (12,209,500)	$ (67,669,200)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	33,800	45,600	777,500
Acquired in-process research and development			7,523,200
Amortization of imputed discount on non-interest bearing notes			45,000
Amortization of discounts on 7%, 7.5% and 10% notes	214,500	57,200	473,700
Amortization of discounts on Platinum notes	13,400	909,000	3,562,100
Amortization of discounts on August 2010 short-term notes		14,300	572,000
Amortization of discounts on February 2012 12% convertible notes	26,900	(4,200)	22,700
Loss on early extinguishment of debt	3,567,800	1,193,500	4,761,300
Loss on settlements of accounts payable	78,300		78,300
Change in warrant and put and note term extension option liabilities	1,635,800	77,900	1,217,200
Stock-based compensation	1,241,300	1,591,300	5,595,600
Expense related to modification of warrants	508,200	741,700	1,249,900
Fair value of Series C preferred stock, common stock, and warrants granted for services prior to the Merger		131,200	1,056,600
Fair value of common stock granted for services prior to the Merger		2,225,500	2,225,500
Fair value of common stock granted for services following the Merger	340,000	452,000	792,000
Fair value of warrants granted for services following the Merger	183,800	564,500	748,300
Fair value of additional warrants granted pursuant to exercises of modified warrants (fiscal year 2013) and under Discounted Warrant Exercise Program (fiscal year 2012)	35,900	138,100	174,000
Fair value of common stock issued for note term modification		22,400	22,400
Interest income on note receivable for stock purchase	(27,600)		(27,600)
Consulting services by related parties settled by issuing promissory notes			44,600
Gain on sale of assets			(16,800)
Changes in operating assets and liabilities:
Unbilled contract payments receivable	106,200	(64,000)
Prepaid expenses and other current assets	46,200	(1,900)	41,700
Security deposits and other assets		2,100	(29,000)
Accounts payable and accrued expenses	1,432,200	744,300	15,918,500
Deferred revenues	(13,200)	(65,600)
Net cash used in operating activities	(3,463,200)	(3,565,800)	(20,971,700)
Cash flows from investing activities:
Purchases of equipment, net	135,400	32,400	816,200
Net cash used in investing activities	(135,400)	(32,400)	(816,200)
Cash flows from financing activities:
Net proceeds from issuance of common stock and warrants, including units	1,185,100	2,679,200	3,985,100
Net proceeds from issuance of preferred stock and warrants			4,198,600
Proceeds from exercise of modified warrants (fiscal 2013) and under Discounted Warrant Exercise Program (fiscal 2012)	262,100	1,166,300	1,428,400
Proceeds from issuance of notes under line of credit			200,000
Proceeds from issuance of 7% note payable to founding stockholder			90,000
Net proceeds from issuance of 7% convertible notes			575,000
Net proceeds from issuance of 10% convertible notes and warrants			1,655,000
Net proceeds from issuance of Platinum notes and warrants	3,222,100		6,922,100
Net proceeds from issuance of 2008/2010 notes and warrants			2,971,800
Net proceeds from issuance of 2006/2007 notes and warrants			1,025,000
Proceeds from issuance of 7% notes payable			55,000
Net proceeds from issuance of August 2010 short-term notes and warrants			800,000
Net proceeds from issuance of February 2012 12% convertible notes and warrants		466,500	466,500
Repayment of capital lease obligations	(16,900)	(14,500)	(117,400)
Repayment of notes	(496,700)	(757,600)	(1,829,100)
Net cash provided by financing activities	4,155,700	3,539,900	22,426,000
Net increase in cash and cash equivalents	557,100	(58,300)	638,100
Cash and cash equivalents at beginning of period	81,000	139,300
Cash and cash equivalents at end of period	638,100	81,000	638,100
Supplemental disclosure of cash flow activities:
Cash paid for interest	225,900	265,400	665,600
Cash paid for income taxes	3,681	1,600	20,481
Supplemental disclosure of noncash activities:
Forgiveness of accrued compensation and accrued interest payable to officers transferred to equity			800,000
Exercise of warrants and options in exchange for debt cancellation			112,800
Settlement of accrued and prepaid interest by issuance of Series C Preferred Stock			35,300
Conversion of 10% notes payable, net of discount, and related accrued interest into Series C Preferred stock			2,050,300
Issuance of Series B-1 Preferred stock for acquired in-process research and development			7,523,200
Conversion of 7% notes payable, net of discount, and related accrued interest into Series B Preferred stock			508,000
Conversion of accounts payable into convertible promissory notes			893,700
Conversion of accounts payable into note payable	1,558,500		4,368,800
Conversion of accounts payable into common stock	103,200	275,400	1,927,300
Conversion of accrued interest on convertible promissory notes into common stock			921,400
Notes receivable from sale of common stock to related parties upon exercise of options and warrants			149,800
Capital lease obligations		19,000	139,700
Recognition of put option and note term extension option liabilities upon issuance of Platinum Notes			141,200
Incremental fair value of put option and note term extension option liabilities from debt modifications			479,400
Incremental fair value of note conversion option from debt modification			1,891,200
Incremental fair value of warrant from debt modifications			276,700
Recognition of warrant liability upon adoption of new accounting standard			151,300
Fair value of warrants issued with August 2010 short term notes			130,900
Note Discount upon issuance of August 2010 short-term notes			320,000
Fair value of warrants issued with February 2012 12% convertible notes		542,000	542,000
Note Discount upon issuance of February 2012 12% convertible notes		495,200	495,200
Conversion of 2006/2007 and 2008/2010 Notes into Units, including accrued interest of $1,365,600		6,174,800	6,174,800
Conversion of all series of pre-Merger preferred stock into Units		14,534,800	14,534,800
Conversion of 2011 Platinum Note into Series A Preferred stock, including accrued interest of $611,100 and conversion premium		5,763,900	5,763,900
Conversion of 7% note payable and accrued interest of $11,500 into common stock and warrants		19,500	19,500
Conversion of accounts payable to Morrison & Foerster, McCarthy Tetrault and Desjardins into notes payable		1,603,400	1,603,400
Accounts payable and cancellation premium converted into 2011 Private Placement Units		169,000	169,000
Accrued interest on Cato Holding Company note converted to note payable		90,800	90,800
Accounts payable settled in December 2011 and May/June 2012 warrant exercises	12,500	267,600	280,100
Insurance premiums settled by issuing note payable	110,100	88,500	198,600
Conversion of accrued interest and fees on February 2012 Notes into 2012 Private Placement Units	92,900		92,900
Accrued interest on July and August 2012 Notes to Platinum converted into Exchange Note	22,600		22,600
Accounts payable settled by issuance of stock or notes payable and stock	104,900		104,900
Accounts payable converted into 2012 Private Placement Units	50,000		50,000
Recognition of warrant liability upon issuance to Platinum of October 2012 Exchange Note and October 2012, February 2013 and March 2013 Investment Notes	1,690,000		1,690,000
Recognition of warrant liability for potential issuance to Platinum of Series A Exchange Warrant under the terms of the October 2012 Agreement	$ 3,068,200		$ 3,068,200